David M. Clifford

Learn More
AIMS To investigate whether there are important sources of heterogeneity between the findings of different clinical trials which administer autologous stem cell treatment for acute myocardial infarction (AMI) and to evaluate what factors may influence the long-term effects of this treatment. METHODS AND RESULTS MEDLINE (1950-January 2011), EMBASE(More)
  • 1